Skip to Content

Tucatinib (TUKYSA®) and trastuzumab in HER2-positive Metastatic Colorectal Cancer

Download PQI pdf 0.19MB

Last Updated: January 8, 2024

By: Matthew Arango, PharmD, BCOP

About this PQI

Understand how to identify eligible patients and manage adverse effects of tucatinib treatment for patients with metastatic colorectal cancer.

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI